메뉴 건너뛰기




Volumn 24, Issue 10, 2008, Pages 2905-2918

Economic evaluation of medication, laser trabeculoplasty and filtering surgeries in treating patients with glaucoma in the US

Author keywords

Costs; Glaucoma; Laser trabeculoplasty; Markov process; Medication; Surgery

Indexed keywords

ALPHA ADRENERGIC RECEPTOR STIMULATING AGENT; ALPHAGAN P; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; BIMATOPROST; BRIMONIDINE; BRINZOLAMIDE; CARBONATE DEHYDRATASE INHIBITOR; CARTEOLOL; DORZOLAMIDE; LATANOPROST; LEVOBUNOLOL; METIPRANOLOL; PROSTAGLANDIN; PROSTAGLANDIN DERIVATIVE; TIMOLOL; TIMOLOL MALEATE; TRAVATAN Z; TRAVOPROST; UNCLASSIFIED DRUG;

EID: 55549125218     PISSN: 03007995     EISSN: None     Source Type: Journal    
DOI: 10.1185/03007990802379996     Document Type: Article
Times cited : (54)

References (15)
  • 1
    • 33644655886 scopus 로고    scopus 로고
    • The number of people with glaucoma worldwide in 2010 and 2020
    • Quigley HA, Broman AT. The number of people with glaucoma worldwide in 2010 and 2020. Br J Ophthalmol 2006;90:262-7
    • (2006) Br J Ophthalmol , vol.90 , pp. 262-267
    • Quigley, H.A.1    Broman, A.T.2
  • 3
    • 4444233602 scopus 로고    scopus 로고
    • An evidence-based assessment of risk factors for the progression of ocular hypertension and glaucoma
    • Friedman DS, Wilson MR, Liebmann JM, et al. An evidence-based assessment of risk factors for the progression of ocular hypertension and glaucoma. Am J Ophthalmol 2004; 138:S19-S31
    • (2004) Am J Ophthalmol , vol.138
    • Friedman, D.S.1    Wilson, M.R.2    Liebmann, J.M.3
  • 4
    • 1842530296 scopus 로고    scopus 로고
    • Causes and prevalence of visual impairment among adults in the United States
    • Congdon N, O'Colmain B, Klaver CC, et al. Causes and prevalence of visual impairment among adults in the United States. Arch Ophthalmol 2004;122:477-85
    • (2004) Arch Ophthalmol , vol.122 , pp. 477-485
    • Congdon, N.1    O'Colmain, B.2    Klaver, C.C.3
  • 5
    • 0042360494 scopus 로고    scopus 로고
    • Risk factors associated with the incidence of open-angle glaucoma: The visual impairment project
    • Le A, Mukesh BN, McCarty CA, et al. Risk factors associated with the incidence of open-angle glaucoma: the visual impairment project. Invest Ophthalmol Vis Sci 2003;44:3783-9
    • (2003) Invest Ophthalmol Vis Sci , vol.44 , pp. 3783-3789
    • Le, A.1    Mukesh, B.N.2    McCarty, C.A.3
  • 7
    • 0031751109 scopus 로고    scopus 로고
    • Direct costs of glaucoma management following initiation of medical therapy. A simulation model based on an observational study of glaucoma treatment in Germany
    • Kobelt G, Jonsson L, Gerdtham U, et al. Direct costs of glaucoma management following initiation of medical therapy. A simulation model based on an observational study of glaucoma treatment in Germany. Graefes Arch Clin Exp Ophthalmol 1998;236:811-21
    • (1998) Graefes Arch Clin Exp Ophthalmol , vol.236 , pp. 811-821
    • Kobelt, G.1    Jonsson, L.2    Gerdtham, U.3
  • 10
    • 0003951278 scopus 로고    scopus 로고
    • Online. American Academy of Ophthalmology. San Francisco: American Academy of Ophthalmology, 2005. Available at:, last accessed 29 January 2008
    • Primary Open-Angle Glaucoma. Preferred Practice Pattern. Online. American Academy of Ophthalmology. San Francisco: American Academy of Ophthalmology, 2005. Available at: http://www.aao.org/education/ guidelines/ppp/poag_new.cfm [last accessed 29 January 2008]
    • Primary Open-Angle Glaucoma. Preferred Practice Pattern
  • 11
    • 1842581327 scopus 로고    scopus 로고
    • The Advanced Glaucoma Intervention Study (AGIS): 13. Comparison of treatment outcomes within race: 10-year results
    • Ederer F, Gaasterland DA, Dally LG, et al. The Advanced Glaucoma Intervention Study (AGIS): 13. Comparison of treatment outcomes within race: 10-year results. Ophthalmology 2004;111:651-64
    • (2004) Ophthalmology , vol.111 , pp. 651-664
    • Ederer, F.1    Gaasterland, D.A.2    Dally, L.G.3
  • 13
    • 0031968095 scopus 로고    scopus 로고
    • Costs of treating primary open-angle glaucoma and ocular hypertension: A retrospective, observational 2-year chart review of newly diagnosed patients in Sweden and the United States
    • Kobelt-Nguyen G, Gerdtham UG, Alm A. Costs of treating primary open-angle glaucoma and ocular hypertension: a retrospective, observational 2-year chart review of newly diagnosed patients in Sweden and the United States. J Glaucoma 1998;7:95-104
    • (1998) J Glaucoma , vol.7 , pp. 95-104
    • Kobelt-Nguyen, G.1    Gerdtham, U.G.2    Alm, A.3
  • 14
    • 27744525491 scopus 로고    scopus 로고
    • Direct costs of glaucoma and severity of the disease: A multinational long term study of resource utilisation in Europe
    • Traverso CE, Walt JG, Kelly SP, et al. Direct costs of glaucoma and severity of the disease: a multinational long term study of resource utilisation in Europe. Br J Ophthalmol 2005; 89:1245-9
    • (2005) Br J Ophthalmol , vol.89 , pp. 1245-1249
    • Traverso, C.E.1    Walt, J.G.2    Kelly, S.P.3
  • 15
    • 30344486940 scopus 로고    scopus 로고
    • A multicenter, retrospective pilot study of resource use and costs associated with severity of disease in glaucoma
    • Lee PP, Walt JG, Doyle JJ, et al. A multicenter, retrospective pilot study of resource use and costs associated with severity of disease in glaucoma. Arch Ophthalmol 2006;124:12-19
    • (2006) Arch Ophthalmol , vol.124 , pp. 12-19
    • Lee, P.P.1    Walt, J.G.2    Doyle, J.J.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.